Teva Pharmaceutical Industries | TEVA - Fremdkapital

Aktienkurs
9,008.00
Täglich Wechseln
-200.00 -2.17%
Monatlich
-14.29%
Jährlich
51.83%
Q1 Prognose
8,931.76




Fremdkapital Veränderung Datum
Aspen Pharmacare ZAR 29.34B 1.93B 2025-12
Cipla INR 2.98B 454.6M 2025-09
Dr.Reddys Laboratories INR 11.61B 29M 2025-12
Guangzhou Baiy CNY 3.56B 252.82M 2025-12
Jiangsu Hengrui CNY 51.42M 5.94M 2025-09
Kalbe Farma IDR 169.81B 37.21B 2025-09
Richter Gedeon HUF 15.14B 537M 2025-12
Sh Fosun Pharma CNY 14.05B 556.38M 2025-09
Sun Pharmaceuticals INR 3.62B 36.4M 2025-09
Teva Pharmaceutical Industries USD 14.99B 1.78B 2025-12